Efficacy and Safety of the Use of SGLT2 Inhibitors in Patients on Incremental Hemodialysis: Maximizing Residual Renal Function, Is There a Role for SGLT2 Inhibitors?

SGLT-2i are the new standard of care for diabetic kidney disease (DKD), but previous studies have not included patients on kidney replacement therapy (KRT). Due to their high risk of cardiovascular, renal complications, and mortality, these patients would benefit the most from this therapy. Residual...

Descripción completa

Detalles Bibliográficos
Autores principales: De La Flor, José C., Villa, Daniel, Cruzado, Leónidas, Apaza, Jacqueline, Valga, Francisco, Zamora, Rocío, Marschall, Alexander, Cieza, Michael, Deira, Javier, Rodeles, Miguel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377393/
https://www.ncbi.nlm.nih.gov/pubmed/37509547
http://dx.doi.org/10.3390/biomedicines11071908

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377393/
https://www.ncbi.nlm.nih.gov/pubmed/37509547
http://dx.doi.org/10.3390/biomedicines11071908

Ejemplares similares